JESSICA BEATTIE: Open Payments
NPI 1811448970 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,645 in 102 payments from 17 companies in 2025. Trend: 2023 $1,980 · 2024 $3,076 · 2025 $2,645
Food & beverage: $2,565Education: $80
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 20 | $901 |
| ABBVIE INC. | 29 | $467 |
| GENZYME CORPORATION | 9 | $368 |
| Janssen Biotech, Inc. | 6 | $174 |
| Regeneron Healthcare Solutions, Inc. | 6 | $142 |
| Lilly USA, LLC | 10 | $118 |
| PFIZER INC. | 4 | $103 |
| Galderma Laboratories, L.P. | 4 | $75 |
| LEO Pharma Inc. | 3 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $65 |
Products named: DAXXIFY, DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, BOTOX, CIBINQO, TALTZ.
Industry payments across GA — which companies pay providers there.
